Trials / Completed
CompletedNCT00841230
Deanxit and Rivotril in Tinnitus Patients
Additional Value of Deanxit in Tinnitus Patients Treated With Rivotril
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- University Hospital, Antwerp · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate whether increased tinnitus reduction can be obtained with Deanxit in patients already receiving Rivotril.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Deanxit | Deanxit 1x/day |
| DRUG | Lactose placebo | Lactose used as placebo |
Timeline
- Start date
- 2009-02-01
- Primary completion
- 2009-07-01
- Completion
- 2009-07-01
- First posted
- 2009-02-11
- Last updated
- 2009-08-11
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT00841230. Inclusion in this directory is not an endorsement.